Cargando…
PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis
This study compared proton pump inhibitors (PPIs) and histamine H2 receptor antagonists (H(2)RAs) for prevention of low-dose aspirin (LDA)-related gastrointestinal (GI) erosion, ulcer and bleeding. Electronic databases including PubMed, Embase, Cochrane Central Register of Controlled Trials, Chinese...
Autores principales: | Mo, Chen, Sun, Gang, Wang, Yan-Zhi, Lu, Ming-Liang, Yang, Yun-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493004/ https://www.ncbi.nlm.nih.gov/pubmed/26147767 http://dx.doi.org/10.1371/journal.pone.0131558 |
Ejemplares similares
-
CNS-Sparing Histamine H(3) Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms
por: Rosa, Arianna Carolina, et al.
Publicado: (2022) -
Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?
por: De Benedetto, Anna, et al.
Publicado: (2015) -
Upper Gastrointestinal Mucosal Injury and Symptoms in Elderly Low-Dose Aspirin Users
por: Shimada, Yuji, et al.
Publicado: (2015) -
Comparison of Proton Pump Inhibitor and Histamine-2 Receptor Antagonist in the Prevention of Recurrent Peptic Ulcers/Erosions in Long-Term Low-Dose Aspirin Users: A Retrospective Cohort Study
por: Chen, Wen-Chi, et al.
Publicado: (2014) -
Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients
por: Mura, Cameron, et al.
Publicado: (2021)